Enlivex Therapeutics : Immediate Report of Meeting -September 13, 2023 at 04:57 pm EDT

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


Form 6-K


Report of...

Related Keywords

Ness Ziona ,Hamerkaz ,Israel ,Washington ,United States ,Tel Aviv ,Israeli ,State Of Israel ,Roger Pomerantz ,Shai Novik ,Gili Hart ,Brian Schwartz ,Abraham Havron ,Oren Hershkovitz ,Company Articles Of Association ,Form Of Enlivex Therapeutics Ltd ,Exchange Commission ,Tel Aviv Stock Exchange ,Companies Law ,Securities Exchange ,Israel The Company ,Company Board Of Directors ,Enlivex Therapeutics Ltd ,Israeli Companies Law ,Israel Securities Authority ,Foreign Private Issuer Pursuant ,Securities Exchange Act ,Nes Ziona ,General Meeting ,Proxy Statement ,Annual Meeting ,Enlivex Therapeutics ,Chief Executive Officer ,Annual General Meeting ,Andrew Singer ,Executive Chairman ,Certified Public Accountants ,Record Date ,Internet Availability ,Proxy Materials ,Israel Companies Regulations ,General Meetings ,Ownership Certificate ,Chief Financial Officer ,Markets ,